Rare target cells can be isolated from a high background of non-target cells using antibodies specific for surface proteins of target cells. A recently developed method uses a medical wire functionalized with anti-epithelial cell adhesion molecule (EpCAM) antibodies for in vivo isolation of circulating tumor cells (CTCs) 1 . A patient-matched cohort in non-metastatic prostate cancer showed that the in vivo isolation technique resulted in a higher percentage of patients positive for CTCs as well as higher CTC counts as compared to the current gold standard in CTC enumeration. As cells cannot be recovered from current medical devices, a new functionalized wire (referred to as Device) was manufactured allowing capture and subsequent detachment of cells by enzymatic treatment. Cells are allowed to attach to the Device, visualized on a microscope and detached using enzymatic treatment. Recovered cells are cytocentrifuged onto membrane-coated slides and harvested individually by means of laser microdissection or micromanipulation. Single-cell samples are then subjected to single-cell whole genome amplification allowing multiple downstream analysis including screening and target-specific approaches. The procedure of isolation and recovery yields high quality DNA from single cells and does not impair subsequent whole genome amplification (WGA). A single cell's amplified DNA can be forwarded to screening and/or targeted analysis such as array comparative genome hybridization (array-CGH) or sequencing. The device allows ex vivo isolation from artificial rare cell samples (i.e. 500 target cells spiked into 5 mL of peripheral blood). Whereas detachment rates of cells are acceptable (50 -90%), the recovery rate of detached cells onto slides spans a wide range dependent on the cell line used (<10 ->50%) and needs some further attention. This device is not cleared for the use in patients.
Introduction
Recently, CellCollector DC01, a medical wire functionalized with anti-EpCAM antibodies for isolating CTCs from peripheral blood of cancer patients, was added to the methodical spectrum of CTC enumeration . However, more comprehensive analysis to investigate heterogeneity among CTCs long for analysis at the individual cell level (i.e. targeted sequencing at the single-cell level). Other cell-based methods are based on immunomagnetic isolation of EpCAM-positive CTCs and single-cell handling based on dielectrophoresis for subsequent molecular genetic analysis 9, 10 . Molecular characterization of CTCs is an important requirement for their useful implementation in a clinical setting and is equally important in basic research of the metastatic cascade. In parallel to CTCs, circulating tumor DNA (ctDNA) has become of great importance as it allows DNA analysis of the tumor burden with minimal technical isolation procedures 11, 12 . The cell based approaches might serve as a complementary contribution as it allows for RNA 13, 14 and protein 15 expression analysis and also for CTC derived cell cultures or xenografts 16, 17 . Although obstacles such as low cell recovery and clearance for the use in patients still need to be overcome, the catch and release method takes an important next step towards characterization of rare target cells.
Protocol
All procedures have been approved by the Ethics Committee of the Medical University of Graz (25-240 ex 12/13). Peripheral blood for spiking experiments was sampled from healthy individuals.
5. Single-cell sampling 1 . Micromanipulation NOTE: Single cells will be added to 2 µL of cell lysis master mix allowing WGA. Prepare master mix according to the number of cells to be processed, calculate extra volumes for loss due to pipetting and place cell lysis master mix on ice.
1. Prepare the cell lysis master mix (components of WGA kit, . Briefly, mix 2.0 µL of reaction buffer, 1.3 µL of octylphenoxypolyethoxyethanol (10% solution), 1.3 µL of 4-(1,1,3,3-tetramethylbutyl)phenyl-polyethylene glycol (10% solution), 2.6 µL of a proteinase K solution, and 12.8 µL RNase/DNase-free water to obtain a master mix for 10 samples (total volume 20 µL). NOTE: For more samples, increase the volumes accordingly. The composition of cell lysis master mix differs from the one used in the alternative procedure utilizing laser microdissection samples (see 5.2.). 2. Use a grease pen to draw an area holding the cell suspension in place. Adjust area and volume if the cell density is too high (i.e. mark a larger area on the glass slide, load 1x PBS and an aliquot of the cell suspension). 3. Pipette the entire stained cell suspension (obtained in step 4.8.) onto the glass slide. 4. Transfer the glass slide to a microscope equipped with a micromanipulator. Let the cells settle for 5 min (Figure 2D and 2H) . 5. Prepare 0.2 mL PCR tubes loaded with 2.0 µL of cell lysis master mix (see step 5.1.1.) and store it on ice. 6. Collect single cells in 1 µL of 1x PBS using the micromanipulator and transfer the cells into a tube containing cell lysis master mix.
NOTE: For transferring micromanipulated cells into the cell lysis buffer place the capillary directly into the 2 µL of lysis solution and eject until bubbles can be seen. 7. Briefly spin down the sample at 2000 x g for 3 s using a desktop microfuge to collect all liquid at the bottom of the tube. Place the samples on ice. 8. Directly proceed to single-cell WGA (see section 6. and Czyż et al. 19 ).
2. Laser microdissection (alternative single-cell sampling method to: 5.1. Micromanipulation) NOTE: The composition of the master mix used in this section differs from the one used in section 5.1 for micromanipulation. Single cells will be added to 4.5 µL of cell lysis master mix (components of WGA kit, 1,3 ,3-tetramethylbutyl)phenyl-polyethylene glycol (10% solution), resp., 2.6 µL of a proteinase K solution and 34.8 µL of RNase/DNase-free water to obtain a master mix for 10 samples (total volume 45 µL). Place the master mix on ice. NOTE: For more samples, increase the volumes accordingly. 2. UV-treat membrane-coated slides suited for laser microdissection. Therefore, place the slides in a DNA cross linker device and expose to highest UV for about 10 min. 3. Assemble the membrane-coated slide in a cytocentrifuge and cytospin the entire cell suspension at 300 x g for 5 min.
NOTE: When using an in-liquid system, where the cells are cytocentrifuged onto the slide in solution, remove the supernatant after cytocentrifugation and apply a dry-spin at 1140 x g for 1 min. 4. Directly proceed to laser microdissection or let the cytospins air-dry overnight and freeze the samples at -20 °C for long term storage. 5. Pipette 4.5 µL of cell lysis master mix into the cap of a 0.2 mL PCR tube and harvest single cells by means of laser microdissection. 6. Retrieve the PCR tube from the laser microdissection microscope and close the tube. Collect all liquid at the bottom of the tube by short-spin and place the sample on ice. 7. Proceed with single-cell WGA or store the isolated samples at -80 °C for up to 1 month before further processing.
Adapter-linker based whole genome amplification 18,19
NOTE: Make sure all necessary master mixes (components of WGA kit, Table of 2. Run pre-annealing of the PCR adapters. Therefore, incubate the pre-annealing master mix in a thermal cycler at 65 °C for 1 min followed by further 49 cycles, 1 min each, with progressively decreasing the temperature by 1 °C/cycle. After 50 cycles (at 15 °C), incubate the master mix at 15 °C until further use. NOTE: This step is necessary to generate asymmetric adapters suitable for ligation (see step 6.6.) with single-cell DNA subjected to MseI restriction digest. 3. After cell lysis, spin down the lysed samples at 2000 x g for 3 s to collect all liquid at the bottom and place it on ice. 4. To fragment DNA, add 2 µL of the DNA digestion mix 1 to each lysed micromanipulated sample or 0.5 µL of the DNA digestion mix 2 to the laser microdissection sample and run restriction digest. Use a thermal cycler with a heated lid at 37 °C for 5 min followed by a restriction enzyme inactivation step at 65 °C for 5 min. NOTE: Digestion at 37 °C may be extended to 3h. This is the only protocol step differing between samples obtained from micromanipulation and samples obtained from laser microdissection. 5. Spin down the samples to collect all liquid at the bottom and place it on ice. 6. For ligating restriction digested DNA and pre-annealed adapters, add 5 
Quality control of WGA products
NOTE: Check the quality of WGA products based on the range of the DNA smear and the number of amplification products after running a 4plex QC-PCR
5
. Run WGA aliquots and respective QC-PCR samples on a 1.0% agarose gel for evaluation.
1. Prepare 100 µM stock solutions of all primers used for 4plex quality control PCR ( Table 1 
Representative Results
Cells after CFSE and nucleic staining can be evaluated using an immunofluorescence microscope equipped with filters for DAPI and FITC. Nuclei present with a bright counterstain in the DAPI channel whereas cytoplasm of the cells show uniform labelling with CFSE with heterogeneous inter-cell intensity (Figure 2A and 2E) . Similar shape and staining intensities are expected from cells attached to the wire ( Figure  2B and 2F) as well as detached from the wire and recovered on a slide (Figure 2D and 2H) .
High cell densities (e.g. >1 000 000 cells/mL) may result in total coverage of the wire with cells when charging the wires. However, lower cell densities, changes in rotation speed during incubation, and the use of different cell lines affect the isolation efficiency and need to be tested separately. When the wires were incubated with 5 mL of HT-29 cells at 100 000 cells/ mL as described in section 2.1., a mean of 254 ± 103 cells (n = 5) were captured on the wires. With the same experiment using LNCaP cells, a mean of 440 ± 319 cells (n = 5) per wire was obtained.
Presenting 500, 5 000, and 50 000 HT-29 cells in a background of 5 mL of peripheral blood to wires (according to protocol section 2.2.) resulted in the capture of 75 ± 18 cells, 25 ± 9 cells, and 47 ± 57 cells (n = 3, each), respectively. If the wire is charged with 15 µL of cell suspension (1 000 000 cells/mL) according to the protocol in section 2.3., up to 1 000 (HT-29) cells may attach to a wire.
Cell detachment efficiencies ranged from 81% in HT-29 cells (range 54.9% -93.2%, and n = 5) to 81% (range 63.51%-92.87%, n = 6) and 91% (range 84.7% -95.3%, n = 6) in LNCaP and VCaP cells, respectively. Similarly, the recovery of detached cells differs between cell lines: A mean of 28% of detached HT-29 cells were recovered by cytocentrifugation. Whereas the recovery rate for LNCaP was lower than 10%, the mean recovery rate for VCaP cells was 55%.
Approximately 75% of single cells subjected to WGA yield high quality WGA products: This is 1) smear of WGA products ranging from 0.1 to > 1 kb (Figure 4 , top panel) and 2) three or four bands in the 4plex quality control PCR (Figure 4, bottom panel) . WGA products can be used for 1) array-CGH profiling meeting the quality criteria for single-cell array-CGH profiles 6, 7 and 2) targeted NGS after re-amplification WGA 
Primer sequence NOTE
5′-gtt cca ata tga ttc cac cc-3′ 100 bp forward primer 5′-ctc ctg gaa gat ggt gat gg-3′ 100 bp reverse primer 5′-agg tgg agc gag gct agc-3′ 200 bp forward primer 5′-ttt tgc ggt gga aat gtc ct-3′ 200 bp reverse primer 5′-agg tga gac att ctt gct gg-3′ 300 bp forward primer 5′-tcc act aac cag tca gcg tc-3′ 300 bp reverse primer 5′-aca gtc cat gcc atc act gc-3′ 400 bp forward primer 5′-gct tga caa agt ggt cgt tg-3′ 400 bp reverse primer Table 1 : Primer sequences for 4plex quality control PCR
Discussion
The described protocol aims at retrieving cells from a functionalized wire (referred to as Device) for ex vivo single-cell genomic analysis. We tested three EpCAM-positive cell lines (HT-29, LNCaP, and VCaP), but in principle, this method can be applied to any cell line expressing EpCAM. EpCAM-positive target cells can be presented to the Device as pure cell suspension (see 2.1.) or mixed into a surplus of background cells (e.g. peripheral blood, see 2.2.). Whereas especially the latter might be used to test isolation capacities under rare cell conditions, fine tuning of the number of cells attached to the wire can be done using the described low-volume approach (see 2.3.). As differences between cell lines are to be expected, suitable cell densities for charging the wire, rotation speed as well as incubation time need to be tested empirically by evaluating the number of attached cells using an immunofluorescence microscope.
For genomic downstream applications at the single-cell level WGA, is required. The WGA method of choice may differ between labs and, in principle, our method is open to all methods than can handle samples obtained from micromanipulation or laser microdissection. In this protocol, we use a method based on enzymatically fragmented DNA due to a better performance as compared to a heat-fragmentation based WGA 7 . Optional, single cells can be forwarded to isothermal WGA allowing subsequent DNA profiling 20, 21 .
The described protocol aims at recovering intact cells after being attached to a new generation of functionalized wires for genomic single-cell analysis. The first generation of functionalized wires, which also represent the only CE-approved in vivo enrichment devices on the market so far, were used for enumerating CTCs in metastasized cancer patients. Previous publications and our own data suggest the in vivo isolation technique to be more sensitive compared to the current gold standard technology 2 . Thus, equipping this in vivo isolation technique with a recovery feature as realized in the Device allows combining high CTC recovery with characterization at the single-cell level.
However, the Device is not cleared for the use in patients, thus, clinical data are not available. Ex vivo applications (i.e. isolating CTCs from peripheral blood after sampling) are not recommended as the technology is adapted to the settings present in the cubital vain, e.g. low diameter of the vain (increasing the probability of direct contact between CTCs and catching antibodies) and long retention time (30 min, allowing 2-3 L of blood to pass the wire). However, as outlined in section 2.2. target cells can also be isolated from mixed samples 7 .
A current limitation of the method is the inefficient recovery of unfixed cells after detachment from the wires. This, however, might be improved by a cell fixation step prior to the detachment treatment.
In summary, this protocol is a first step towards the combined use of an in vivo isolation technique with cell recovery for genetically characterizing single cells. Further efforts need to address the optimization of the cell recovery and clearance for its application in patients 1, 2 . However, personalized medicine for treatment monitoring and therapy decisions is beyond enumeration of CTCs. Thus, this method is a first step towards genomic CTC characterization at the single cell level.
Applications towards single-cell transcriptome analysis seem feasible as intact cells are harvested. However, it remains to be assessed whether the recovering procedure has an impact on RNA integrity (e.g. forwarding recovered single cells to direct lysis followed by RT-qPCR 22 ). If successful, characterization of single cells (e.g. CTCs) can be shifted to the transcriptome level , allowing more detailed analyses. In this regard, RNA-seq using Smart-seq2 provides a valuable tool for RNA downstream analysis of single cells as the preamplified cDNA (obtained during RNA-seq library preparation) can be subjected to quantitative PCR. This will allow a combined target and screening-based analysis of single recovered cells 22, 23 .
The current functionalized wires are based on anti-EpCAM antibodies which is a widely used epithelial marker for positive selection of CTCs 24 .
As several CTCs might downregulate epithelial markers such as cytokeratins or EpCAM 25 , adding antibodies such as HER2/new would increase the chance of CTC isolation. Several antibody based enrichment strategies have been developed and reviewed by Ferreira et al. in 2016 26 . A mixture of antibodies immobilized on a wire could be a future improvement of the technology leading to the isolation of a higher number and additional subtypes of CTCs.
It is mandatory for all steps involving wire handling to keep the functional part of the wire submerged in solution in order to maintain its functionality. We recommend to place the wire in 1x PBS during evaluation (microscope; e.g. steps 3.1. -3.3.) and storage. In order to avoid inappropriate staining, we recommend using freshly prepared staining solution in steps 1.2.1. and 1.2.2. Weakly stained cells hamper cell counting on the wire and may lead to the underestimation of the attached cells.
It is necessary to avoid plugging the Pasteur pipette with the rubber cap when inserting the wire in the Pasteur pipette for subsequent loading of the cell suspension (step 2.3.4.). The rubber cap is used to hold the wire in place so that the functional part is situated inside the tip of the Pasteur pipette. If the cap is attached too firmly to the rear of the Pasteur pipette, loading of the cell suspension is not possible. In this case, ease the cap such that the air which is displaced by the loaded cell suspension can leave the pipette.
Bending the wire is crucial for its orientation during the cell counting in steps 3.2. and 3.3. Mount the wires using the adhesive tape such that the non-functional end of the wire comes to lie to one side. After scanning of the entire length of the functional part, the wire is rolled 180° so the other half of the functional wire can be scanned. This step is important for initial experiments to assess the number of cells on the wire. Once the number of cells for a certain cell line and procedure is evaluated, the procedure can be repeated without cell counting (e.g. only checking for presence of cells or omitting this step). Careful pipetting is crucial to avoid cell loss when reducing the volume of the supernatant in step 4.8. Make sure pipetting is done smoothly without causing turbulences to the pellet.
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